Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Aum Cardiovascular releases preliminary data from Turbulence study
Aum Cardiovascular today released preliminary results from the pivotal clinical trial of its Cadence heart disease diagnostics device, touting the device’s efficacy at detecting significant obstructive coronary artery disease.
Aum’s Cadence is designed to identify obstructions in the coronary arteries by detecting acoustic signals generated by the turbulence created as blood flows past the obstruction, according to the company. Read more
4. Court quashes American Medical Systems subpoenas in pelvic mesh case, to mull sanctions
The federal court overseeing the multidistrict litigation over pelvic mesh products made by American Medical Systems, the erstwhile women’s health business once owned by Endo International, is mulling sanctions on the company after quashing a 2nd round of subpoenas sent to an outside witness.
Endo, which acquired AMS in 2011 for $2.9 billion, in 2015 dealt the men’s urology portion of the business to Boston Scientific for $1.65 billion. In March of this year the company shut down the Astora women’s health business “as it did not align with the company’s strategic direction and to reduce the additional exposure to mesh-related product liability,” according to the filing. Read more
3. Appeals court reverses AngioScore win over TriReme
The U.S. Court of Appeals for the Federal Circuit overturned a ruling in favor of AngioScore in a patent infringement case between it and TriReme Medical and a pair of related companies.
The court ruled that an earlier decision from the United States District Court for the Northern District of California “improperly exercised supplemental jurisdiction over state-law claims,” but not in denying attorney fees. Read more
2. Boston Scientific launches Dakota nitinol kidney stone retrieval device
Boston Scientific said today it launched its Dakota nitinol retrieval device designed for kidney stone retrieval in the U.S. and Europe.
The Dakota stone retrieval device is designed to work with kidney stones of multiple sizes, ranging from 1 mm to 10 mm, Marlborough, Mass.-based Boston Scientific. Read more
1. Trump win augurs well for healthcare stocks
Donald Trump’s shocking upset in the U.S. presidential race augurs well for healthcare stocks, as industry can expect lower taxes, and deregulation and the dismantling of Obamacare – including the medical device tax. Read more
The post MassDevice.com +5 | The top 5 medtech stories for November 9, 2016 appeared first on MassDevice.